Whilst CGRP is a vasodilator like NTG, it is a large peptide in molecular structure and, therefore, may not penetrate the blood–brain barrier well in the same way as NO, and may exert at least some of its actions in migraine peripherally. Here, OPA1 is linked to migraine disorder.